Advice to Investors: Own Anything But the Top 10 Companies
March 19, 2024
Harrington, Jenny Van Leeuwen
Smart Pills Deliver Drug Benefits with Fewer Side Effects
November 12, 2023
Vandermosten, John
Smoking Cessation Biotech Is Top M&A Candidate
August 18, 2022
Vandermosten, John
Slowing of Clinic Trial Data Hampers Early-Stage Biotechs
March 18, 2022
Nierengarten, David
Midcap and Small-Cap Biopharma Opportunities a Better Way to Go in 2021
September 30, 2020
Singh, Hartaj
Using an Exchange-Traded Fund to Invest in Infectious Disease
September 04, 2020
Masucci, Samuel, Panettieri Jr., Reynold A.
Outperforming Over a Full Market Cycle with Less Volatility
December 13, 2019
Benowitz, Jason
Buying Solid Stocks When They Are Undervalued
May 10, 2019
Kahn, Thomas G.
Staying Contrarian with a Research-Driven, Value-Oriented Approach
September 07, 2018
Kahn, Thomas G.
Managing an International High Dividend Yield Strategy
June 01, 2018
Buchwald, Richard E., Kline, Marvin I.
Drug Pricing Power Moves from Pharmaceutical Companies to Pharmacy Benefit Managers
March 10, 2017
McGarry, Stephen
Finding Undervalued Assets in the Biotech Sector
November 18, 2016
Adams, Douglas N.
Looking for Biopharmaceuticals with Disruptive Innovation and Medicines Initiatives
August 12, 2016
Amusa, Gbola
Using Asset-Class Flexibility and Downside Protection to Generate Income
May 06, 2016
Caputo, Giorgio, Slein, Sean
Investing in Companies with Disruptive Technologies
March 28, 2016
Cuculich, Robert F.
Innovation and True Technology Solutions Key to Health Care IT Success
October 23, 2015
Rubis, Steve
Faster FDA Approvals and Paradigm-Shifting Breakthroughs Boost Pharma Stocks
March 28, 2014
Focusing on Income While Capturing Capital Appreciation
March 12, 2014
Long-Term Value With a Specialization in International Equities
October 18, 2013
Increased Biotech Productivity and Innovation Reflected in FDA-Approved Drugs
August 23, 2013
New Product Generation and an Easing Regulatory Environment in Biopharmaceuticals
August 05, 2013
FDA Approvals Accelerate and Opportunities Arise in Hepatitis C Market
April 08, 2013
Identifying Hidden Value and Market Opportunities in Biotech Companies
March 21, 2013
Product Pipeline & Diversification Are Key In Pharma - Dr. Jon Lecroy, M.d. - Mkm Partners
November 14, 2011
Defensive Plays In The Defense Space - Michael F. Ciarmoli - Keybanc Capital Markets Inc.
November 14, 2011
A Focus On Capital Allocation For Oil & Gas E&ps - Joseph Magner - Macquarie Group Limited
July 11, 2011
Nano Manufacturing Prospects In Semiconductors - Daniel Heyler - Bank Of America Merrill Lynch (asia Pacific) Ltd.
June 13, 2011
Investing In Small- & Midcap Biotech Companies - Dr. Jason Kantor - Rbc Capital Markets
April 04, 2011
Investing In Domestic Large-cap Companies - Degas. A. Wright - Decatur Capital Management, Inc.
January 10, 2011
Med Tech As Health Care System Cost Reducer - Scott Gleason - Stephens Inc.
November 15, 2010
Conservative & Flexible Active Portfolio Management - Sean Chaitman - Shelter Rock Management, Llc
September 20, 2010
Transparency In Global Equity Investing - Felicity Smith & Richard Greenwood - Bedlam Asset Management
June 14, 2010
Overview Of Midwestern Regional Bank Metrics - Craig Siegenthaler - Credit Suisse
April 05, 2010
Large Cap Value Investing - Daniel G. Lysik - Pratt Capital Llc
March 22, 2010
Investing In Telecom Services - Christopher C. King - Stifel, Nicolaus & Company
November 02, 2009
Canadian Stocks With Growth & Value Potential - Neil Wickham - Wickham Investment Counsel Inc.
October 19, 2009
Post-crunch Trends In Biotechnology - Dr. Liana Moussatos - Wedbush Morgan Securities, Inc.
October 19, 2009
SUSTAINABLE INVESTING WITH ESG ANALYSIS - CHRISTOPHER H. BROWN - PAX WORLD MANAGEMENT CORP.
November 17, 2008
ROUNDTABLE FORUM: SEMICONDUCTORS
September 15, 2008
EMERGING & ENABLING NANOTECHNOLOGIES - PETER J. CONLEY - MDB CAPITAL GROUP LLC
October 09, 2006
RICHARD ASTER JR. - ASTER INVESTMENT MANAGEMENT
September 04, 2006
COMMUNICATIONS EQUIPMENT: RICHARD CHURCH - C.E. UNTERBERG, TOWBIN
July 11, 2006
PULMONARY ARTERIAL HYPERTENSION: ANDREW FEIN - C.E. UNTERBERG, TOWBIN
July 03, 2006
Stacey Renner - Ch Energy Group Inc (chg)
May 05, 2006
DAVID YUCIUS JR. - AURORA INVESTMENT COUNSEL
February 27, 2006
STEPHEN PATTEN - SECTORAL ASSET MANAGEMENT INC
February 27, 2006
AUTOMOTIVE DEALERS: JOHN TOMLINSON - MAJESTIC RESEARCH
January 16, 2006
AGRIBUSINESS & PACKAGED FOOD COMPANIES: CHRISTINE MCCRACKEN - FTN MIDWEST SECURITIES CORP
November 14, 2005
L.FRIDAY / P.SWANSON - KING INVESTMENT ADVISORS INC
November 14, 2005
Deborah Miller - Ascendent
September 16, 2005
ANDREW BERKIN - FIRST QUADRANT LP
September 05, 2005
DRUG DELIVERY & DIABETES MANAGEMENT: ANDREW FORMAN - WR HAMBRECHT & CO
July 01, 2005
K.CRONK / T.LAPOINTE - COLUMBIA MANAGEMENT GROUP
June 27, 2005
CHRISTENSEN / SHERIDAN / VAUGHAN / WILLIAMS IV - DAVID VAUGHAN INVESTMENTS INC
February 14, 2005
ROGER HURST - ASPENBIO INC (APNB)
October 29, 2004
ONCOLOGY & CARDIOVASCULAR COMPANIES: RENI BENJAMIN - RODMAN & RENSHAW INC
October 26, 2004
CHRIS HUNT - DIGITAL CLASSICS PLC (DCT.L)
October 08, 2004
MARK YOSELOFF - SHUFFLE MASTERS INC (SHFL)
September 13, 2004
OILY SERVICES & EQUIPMENT: KAREN DAVID-GREEN - CALYON SECURITIES (USA) INC
August 01, 2004
KEVIN CAREY - 1ST SOURCE CORPORATION INVESTMENT ADVISORS INC
July 19, 2004
LARGE & MID-CAP BIOTECHNOLOGY COMPANIES: LEI ZHONG - RODMAN & RENSHAW
May 03, 2004
DEPARTMENT STORES, DISCOUNTERS & DOLLAR STORES: SHARI EBERTS - J.P. MORGAN CHASE
April 05, 2004
TOM HICKEY - TULLOW OIL PLC (TLW)
March 15, 2004
M.HARDY / G.SWEENEY - NORTHERN CAPITAL MANAGEMENT COMPANY
March 08, 2004
Kshitij Mohan - International Remote Imaging Systems Inc (iri)
September 29, 2003
Selling Protection & Revenue Assurance To Technology Companies: Garrett Melby - Safeguard Scientifics Inc
September 23, 2003
Daniel Glassman - Bradley Pharmaceuticals Inc (bdy)
May 27, 2003
Semiconductors & Computer Hardware Companies: Eric Rothdeutsch - Friedman, Billings, Ramsey Group Inc
May 27, 2003
Michele Ward - Retirement System Investors Inc
April 28, 2003
Payment & Financial Processing: Wayne Johnson Iii - Suntrust Robinson Humphrey
April 01, 2003
David Rolfe - Wedgewood Partners Inc
January 20, 2003
Drug Delivery Companies: Mara Goldstein - Cibc World Markets
November 18, 2002
Daniel Korpolinski - Stressgen Biotechnologies Corp (ssb:tse)
November 01, 2002
Outlook For Managed Care: John Rex - Bear, Stearns & Co
September 13, 2002
Arno Mayer - Steinberg Global Asset Management
August 26, 2002
Fixed Wireless Equipment: Colin Mcardle - Bear, Stearns & Co
June 12, 2002
Jerome Walther - Church Capital Management
May 27, 2002
Gold Stocks: Daniel Mcconvey - Goldman Sachs & Co
May 27, 2002
B.myszkowski / R.drake - Chicago Capital Management
April 01, 2002
Jeffrey Felman - Weber Fulton & Felman Investment Counsel Llc
March 25, 2002
Fred Froewiss - Kinetics Asset Management Inc
March 11, 2002
H.howard Cooper - Teton Petroleum Company (ttpt)
March 04, 2002
John Mclain - Invista Capital Management
February 04, 2002
David Mullen - Allscripts Healtcare Solutions Inc (mdrx)
February 02, 2002
Investing In The Pharmaceutical Industry: Sergio Traversa - Merlin Biomed Group
December 05, 2001
Saks Medscience Fund: David Saks - Saks Medscience Fund
December 05, 2001
Sean Mcleod / Robert Mcdougall - Marshall & Ilsley Investment Management
November 26, 2001
Robert Bernabucci - Ups Capital Corporation (ups)
November 05, 2001
Medical Device Companies / Small & Mid-cap: Charles Olsziewski - Ubs Warburg
October 12, 2001
Large Cap Biotechnology Stocks: Ronald Renaud - Bear, Stearns & Co
September 14, 2001
Thomas Mcintyre - Dessauer & Mcintyre Asset Management
June 18, 2001
John Klein - People's Bank (pbct)
February 26, 2001
Richard Parry - Tom Johnson Investment Management
January 29, 2001
Eric Miller - Heartland Advisors Inc
January 15, 2001
